[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Pharmaceuticals Company Research Reports

Pharmaceuticals companies are involved into development, production as well as marketing of an extensive variety of medicines. The pharmaceuticals industry is represented by innumerable companies. Small biotechnology and biopharmaceutical manufacturers, mid-sized specialty companies, large multi-nationals enterprises are amid the world pharma companies.

Appearance of new products; introduction of new product costs structures and modes of healthcare delivery; modification of product cost, offerings and design; growing public scrutiny; scientific researches in the fields of nanotechnology, bioengineering, etc. are among trends contributing to changes in the pharmaceutical industry.

Johnson & Johnson, Pfizer, Inc., Roche Holding AG, Novartis International AG, Abbott Laboratories, etc. are amid behemoths of the pharmaceutical industry.

Within this MarketPublishers’ catalogue there are innumerable reports featuring pharmaceutical companies’ overviews. The research reports provide a state-of-the-art picture of the pharma market including the analyses of the pharmaceuticals companies. Evaluation of companies’ strategies and data on products offerings are available in the research studies.

Publications found: 3,987
Sort by:

Societe de Promotion Pharmaceutique du Maghreb SA Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Societe de Promotion Pharmaceutique du Maghreb SA Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Societe de Therapeutique Marocaine - Sothema S.A. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Societe de Therapeutique Marocaine - Sothema S.A. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Socrus Bio Sciences Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Socrus Bio Sciences Limited Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Sogo Clinical Holdings Co.,Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Sogo Clinical Holdings Co.,Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Soiken Holdings Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Soiken Holdings Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Solagran Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Solagran Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Soligenix, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Soligenix, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Solvay Pharma India Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Solvay Pharma India Limited Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Somaxon Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Somaxon Pharmaceuticals, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Sopharma AD-Sofia Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Sopharma AD-Sofia Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Sorrento Therapeutics, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Sorrento Therapeutics, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Sosei Co. Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Sosei Co. Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Southwest Pharmaceutical Co. Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Southwest Pharmaceutical Co. Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Southwest Synthetic Pharmaceutical Corporation Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Southwest Synthetic Pharmaceutical Corporation Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Spectrum Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Spectrum Pharmaceuticals, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Spencer Pharmaceutical Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Spencer Pharmaceutical Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Sports Supplement Group, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Sports Supplement Group, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

SS Organics Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

SS Organics Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Stada-Arzneimittel AG Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Stada-Arzneimittel AG Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Stallergenes SA Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Stallergenes SA Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Standard Chemical & Pharmaceutical Co., Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Standard Chemical & Pharmaceutical Co., Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

STAR Pharmaceutical Limited. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

STAR Pharmaceutical Limited. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Starpharma Holdings Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Starpharma Holdings Limited Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Stellar Biotechnologies, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Stellar Biotechnologies, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Stellar Pharmaceuticals Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Stellar Pharmaceuticals Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Stem Cell Authority, Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Stem Cell Authority, Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Stem Cell Innovations, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Stem Cell Innovations, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Stem Cell Therapeutics Corp. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Stem Cell Therapeutics Corp. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

StemCells Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

StemCells Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Stirling Products Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Stirling Products Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Strategic Diagnostics Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Strategic Diagnostics Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Strides Arcolab Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Strides Arcolab Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Sucampo Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Sucampo Pharmaceuticals, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Summit Corporation plc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Summit Corporation plc Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Sun Pharma Advanced Research Company Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Sun Pharma Advanced Research Company Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Sun Pharmaceutical Industries Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Sun Pharmaceutical Industries Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Sunesis Pharmaceuticals Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Sunesis Pharmaceuticals Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Sunmax Biotechnology Co., Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Sunmax Biotechnology Co., Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Sunrise Biotech Holding Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Sunrise Biotech Holding Limited Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Sunshine Biopharma, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Sunshine Biopharma, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Sunwin International Neutraceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Sunwin International Neutraceuticals, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Sunzen Biotech Berhad Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Sunzen Biotech Berhad Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

SuperGen Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

SuperGen Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Surya Pharmaceutical Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Surya Pharmaceutical Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Suvanza Pharma, LLC Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Suvanza Pharma, LLC Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Suven Life Sciences Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Suven Life Sciences Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Swedish Orphan Biovitrum AB Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Swedish Orphan Biovitrum AB Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Swiftsure International, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Swiftsure International, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Swiss Medica Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Swiss Medica Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Sygnis Pharma AG Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Sygnis Pharma AG Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Filters

Search

Publishers

2,237
1,678
37
6
2
1
1
21
2
1
1

Regions

1,352
441
361
240
234
179
155
127
100
90
84
73
65
62
44
27
27
24
20
19
19
19
19
18
17
15
14
13
12
11
11
8
7
7
6
5
5
5
5
4
3
2
2
2
2
2
2
2
2
2
2
2
2
1
1
13

Price

Date

Pages

Offers